|
시장보고서
상품코드
2050987
만성질환 관리 시장 : 질환 유형별, 서비스 유형별, 제공 형태별, 최종사용자별, 지역별Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography |
||||||
만성질환 관리 시장은 2026년에 74억 달러로 추정되고, 2033년까지 182억 6,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 13.8%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 74억 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 13.80% | 2033년 시장 규모 예측 : | 182억 6,000만 달러 |
당뇨병, 암, 심혈관질환(CVD), 만성폐쇄성폐질환(COPD), 천식 등 만성질환은 지속적인 치료가 필요하고 일상생활에 제약이 따르는 장기적인 건강 상태입니다. 흡연을 피하고 건강한 체중을 유지하는 등 생활습관을 개선하면 대부분 예방할 수 있습니다. 하지만 바쁜 스케줄과 스트레스가 많은 생활로 인해 이러한 질환을 관리하기가 어려워지고 있습니다. 이에 따라 더 나은 만성질환 관리 기술에 대한 수요가 증가하고 있습니다. 원격 환자 모니터링의 다양한 기술 발전과 의료 인프라 개선을 위한 정부의 이니셔티브 확대는 가까운 시일 내에 시장 성장을 견인할 것으로 보입니다.
시장 역학:
세계 만성질환 관리 시장의 성장은 여러 만성질환을 앓고 있는 노인 증가, 비만과 식습관 변화로 인한 당뇨병 및 심혈관 질환과 같은 생활습관병 발병률 증가, 조기 발견 및 질병 관리의 이점에 대한 인식 증가, 디지털 헬스 솔루션의 기술 발전, 의료비 상승을 억제하기 위한 각국 정부 및 민간 기업의 노력에 힘입어 성장하고 있습니다. 를 억제하기 위한 각국 정부 및 민간단체의 노력 등의 요인에 의해 주도되고 있습니다. 그러나 데이터 프라이버시에 대한 우려, 원격 모니터링 장비 및 서비스 도입 비용, 개발도상국의 숙련된 의료진 부족으로 인해 더 빠른 보급을 저해할 수 있습니다. 여러 질병을 관리할 수 있는 통합 플랫폼의 개발, AI와 웨어러블 기술의 역할 확대, 개인화된 헬스케어에 대한 관심 증가는 시장 기업들에게 유망한 성장 기회를 제공합니다.
본 조사의 주요 특징:
세계의 만성질환 관리 시장에 대해 조사 분석했으며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년) 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
이 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
또한 이 보고서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들이 채택하고 있는 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
이 보고서는 다음과 같은 매개 변수를 기반으로 세계 만성 질환 관리 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
이번 조사에 참여한 주요 기업으로는 IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum(UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, 그리고 Healthwise 등이 있습니다. Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, Healthwise 등이 있습니다.
이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 입각한 의사결정을 내릴 수 있도록 도와줄 것입니다.
세계 만성 질환 관리 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
이해관계자들은 세계 만성질환 관리 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 만성질환 관리 시장 : 질환 유형별, 2021년-2033년
제5장 세계의 만성질환 관리 시장 : 서비스 유형별, 2021년-2033년
제6장 세계의 만성질환 관리 시장 : 유통 모드별, 2021년-2033년
제7장 세계의 만성질환 관리 시장 : 최종사용자별, 2021년-2033년
제8장 세계의 만성질환 관리 시장 : 지역별, 2021년-2033년
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 조사 방법
LSH 26.06.16Chronic Disease Management Market is estimated to be valued at USD 7.40 Bn in 2026 and is expected to reach USD 18.26 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7.40 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.80% | 2033 Value Projection: | USD 18.26 Bn |
Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.
Market Dynamics:
Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.
Key features of the study:
This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market
Detailed Segmentation-
- Disease Type Insights (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Cancer
- Chronic Kidney Disease
- Others (Arthritis, etc.)
- Service Type Insights (Revenue, USD Bn, 2021 - 2033)
- Disease Management Programs
- Remote Patient Monitoring
- Telehealth Services
- Others (Diagnostic Services, etc.)
- Delivery Mode Insights (Revenue, USD Bn, 2021 - 2033)
- On-premise
- Web-based
- Cloud-based
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Home Care Settings
- Others (Pharmaceutical Companies, etc.)
- Regional Insights (Revenue, USD Bn 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna (a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Service Type
- Market Snapshot, By Delivery Mode
- Market Snapshot, By End User
- Market Snapshot, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Chronic Disease Management Market, By Disease Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Chronic Kidney Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Chronic Disease Management Market, By Service Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Disease Management Programs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Remote Patient Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Telehealth Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Chronic Disease Management Market, By Delivery Mode, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- On-premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Web-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Cloud-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Chronic Disease Management Market, By End User, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Home Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Chronic Disease Management Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Company Profiles
- UnitedHealth Group
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CVS Health
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cigna
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Anthem, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Aetna (a CVS Health company)
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mayo Clinic
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Kaiser Permanente
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Humana Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Teladoc Health, Inc.
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- McKesson Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cerner Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Epic Systems Corporation
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Roche Holding AG
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johns Hopkins Medicine
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GE Healthcare
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Philips Healthcare
- Company Highlights
- Method Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- UnitedHealth Group
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
